» Articles » PMID: 14726813

Technical Standards and Guidelines for Huntington Disease Testing

Overview
Journal Genet Med
Publisher Elsevier
Specialty Genetics
Date 2004 Jan 17
PMID 14726813
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

One mission of the ACMG Laboratory Quality Assurance (QA) Committee is to develop standards and guidelines for clinical genetics laboratories, including cytogenetics, biochemical, and molecular genetics specialties. This document was developed under the auspices of the Molecular Subcommittee of the Laboratory QA Committee by the Huntington Disease (HD) Working Group. These guidelines are not to be interpreted as restrictive or the only approach but to provide a helpful guide. Certainly, appropriately trained and credentialed laboratory directors have flexibility to utilize various testing platforms and design testing strategies with considerable latitude. We felt that it was essential to include technique-specific guidelines of several current technologies commonly used in laboratories providing HD testing, because the technologies discussed are available commercially and are widely utilized. We take the view that these technologies may change, and thus this document may change with future review.

Citing Articles

Uncovering the Genetic and Molecular Features of Huntington's Disease in Northern Colombia.

Ahmad M, Rios-Anillo M, Acosta-Lopez J, Cervantes-Henriquez M, Martinez-Banfi M, Pineda-Alhucema W Int J Mol Sci. 2023; 24(22).

PMID: 38003344 PMC: 10671691. DOI: 10.3390/ijms242216154.


Quantifying mutant huntingtin protein in human cerebrospinal fluid to support the development of huntingtin-lowering therapies.

Vauleon S, Schutz K, Massonnet B, Gruben N, Manchester M, Buehler A Sci Rep. 2023; 13(1):5332.

PMID: 37005488 PMC: 10067853. DOI: 10.1038/s41598-023-32630-4.


Clustering and prediction of disease progression trajectories in Huntington's disease: An analysis of Enroll-HD data using a machine learning approach.

Ko J, Furby H, Ma X, Long J, Lu X, Slowiejko D Front Neurol. 2023; 13:1034269.

PMID: 36793800 PMC: 9923354. DOI: 10.3389/fneur.2022.1034269.


Human pluripotent stem cell-derived brain organoids as in vitro models for studying neural disorders and cancer.

Luo J, Li P Cell Biosci. 2021; 11(1):99.

PMID: 34049587 PMC: 8161602. DOI: 10.1186/s13578-021-00617-1.


Is Ataxia an Underestimated Symptom of Huntington's Disease?.

Franklin G, Camargo C, Meira A, Pavanelli G, Milano S, Germiniani F Front Neurol. 2020; 11:571843.

PMID: 33281707 PMC: 7689004. DOI: 10.3389/fneur.2020.571843.